Top 5 Medical Stocks To Own For 2019


Ziopharm Oncology (NASDAQ:ZIOP) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Saturday.

According to Zacks, “ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. “


Get Ziopharm Oncology alerts:

A number of other analysts have also issued reports on the company. BidaskClub lowered Ziopharm Oncology from a “sell” rating to a “strong sell” rating in a research note on Thursday, January 11th. ValuEngine lowered Ziopharm Oncology from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 1st. Finally, HC Wainwright set a $10.00 price target on Ziopharm Oncology and gave the stock a “buy” rating in a research note on Monday, March 5th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $7.50.

Top 5 Medical Stocks To Own For 2019: Barnes Group, Inc.(B)


Advisors’ Opinion:

  • [By Ethan Ryder]

    Jane Street Group LLC purchased a new position in shares of Barnes Group Inc. (NYSE:B) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,741 shares of the industrial products company’s stock, valued at approximately $284,000.

  • [By Logan Wallace]

    Media stories about Barnes Group (NYSE:B) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Barnes Group earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media headlines about the industrial products company an impact score of 44.8496050074204 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Ethan Ryder]

    Sei Investments Co. decreased its holdings in Barnes Group Inc. (NYSE:B) by 98.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,440 shares of the industrial products company’s stock after selling 174,991 shares during the quarter. Sei Investments Co.’s holdings in Barnes Group were worth $206,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Barnes Group (NYSE: B) and ARC Group WorldWide (NASDAQ:ARCW) are both industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Top 5 Medical Stocks To Own For 2019: CVS Health Corporation(CVS)


Advisors’ Opinion:

  • [By Paul Ausick]

    CVS Health Corp. (NYSE: CVS) traded down about 1.8% Tuesday and posted a new 52-week low of $60.50 after closing Monday at $61.60. The stock’s 52-week high is $84.00. Volume totaled about 5 million, about half the daily average. The company had specific news.

  • [By Adam Levy]

    There are two large mergers in the healthcare industry that are under scrutiny as well. CVS (NYSE: CVS) and Aetna (NYSE: AET) agreed to a $69 billion merger last October. The combined company would include a tripod of healthcare services including a retail pharmacy, a health insurer, and a pharmacy benefits manager. That’s some significant vertical integration that would create quite an advantage over competitors.

  • [By Keith Speights]

    CVS Health (NYSE:CVS) started off 2018 with solid first-quarter results. The company’s retail business looked especially good, bolstered by a rough flu season and the Easter holiday. But the first quarter is now in CVS Health’s rear-view mirror. What lies ahead for the pharmacy giant?

  • [By Demitrios Kalogeropoulos]

    CVS Health(NYSE:CVS) beat the market last month, rising 12% compared to a roughly flat S&P 500, according to data provided by S&P Global Market Intelligence.

Top 5 Medical Stocks To Own For 2019: Nordson Corporation(NDSN)


Advisors’ Opinion:

  • [By Steve Symington]

    Nordson Corporation(NASDAQ:NDSN)announced solid fiscal second-quarter 2018 results on Monday after the market closed, including an expected decline in organic volume that was more than offset by acquisitive growth.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nordson (NDSN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Victory Capital Management Inc. grew its stake in shares of Nordson Co. (NASDAQ:NDSN) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,868 shares of the industrial products company’s stock after purchasing an additional 1,612 shares during the period. Victory Capital Management Inc.’s holdings in Nordson were worth $2,300,000 as of its most recent SEC filing.

  • [By Motley Fool Staff]

    Nordson (NASDAQ:NDSN) Q2 2018 Earnings Conference CallMay. 22, 2018 8:30 a.m. ET


    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Medical Stocks To Own For 2019: Stag Industrial, Inc.(STAG)

Advisors’ Opinion:

  • [By Tyler Crowe]

    With these basic requirements in mind, I just added two dividend stocks I think will fit this mold well in my retirement account: renewable power asset owner TerraForm Power (NASDAQ:TERP)and industrial real estate investment trust STAG Industrial (NYSE:STAG). Here’s why I think these stocks fit my mold for high-yield dividend stocks — and why you may want to consider them for your own portfolio.

  • [By Neha Chamaria]

    To be able to cut a check each month and maintain or raise the payout requires a company to have tenable confidence in its profit-making and cash-generating capabilities. It’s easier said than done, which is why while most companies pay dividends quarterly, and only around 40 publicly listed companies pay a dividend every month. Three such companies worth watching areSTAG Industrial (NYSE:STAG), Realty Income (NYSE:O),and Pembina Pipeline (NYSE:PBA).

  • [By Logan Wallace]

    BNP Paribas Arbitrage SA grew its position in shares of STAG Indl Inc/SH SH (NYSE:STAG) by 35.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,048 shares of the real estate investment trust’s stock after buying an additional 7,604 shares during the period. BNP Paribas Arbitrage SA’s holdings in STAG Indl Inc/SH SH were worth $695,000 at the end of the most recent reporting period.

Top 5 Medical Stocks To Own For 2019: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Endologix (NASDAQ:ELGX) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

Leave a Reply

Your email address will not be published. Required fields are marked *